GATA3 mutations as a whole displayed a marginally significant trend to improved overall survival only in ER-positive patients in the TCGA and METABRIC cohorts [ 25 , 46 ] but not in a smaller Dutch study [ 76 ].
← all excerpts
Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity.
1
—
—